Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator–controlled VOYAGE 1/2 trials

Sang Woong Youn, Dae Young Yu, Tae Yoon Kim, Byung Soo Kim, Seung Chul Lee, Jeung Hoon Lee, Yong Beom Choe, Joo Heung Lee, Jee Ho Choi, Joo Young Roh, Seong Jin Jo, Eun So Lee, Min Kyung Shin, Min Geol Lee, Jingzhi Jiang, Young Ja Lee

Department of Dermatology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator–controlled VOYAGE 1/2 trials'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator–controlled VOYAGE 1/2 trials

Fingerprint

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science